{
  "release_id": "a25293eeae6350fb",
  "id": "cardio:fibrates",
  "owner": "cardio",
  "kind": "drug",
  "slug": "fibrates",
  "name": "Fibrates",
  "aliases": [
    "Fibric acid derivatives",
    "Fibric acids"
  ],
  "atlases": [
    "cardio"
  ],
  "summary_plain": "Fibrates are cholesterol-lowering medicines that lower triglycerides. MedlinePlus says they do this in several ways, including by reducing the triglycerides the liver makes, and that they may also raise HDL cholesterol and lower LDL cholesterol a little. A US label for one fenofibrate product (Antara) calls it a PPAR alpha agonist. This is the class page; one member substance, fenofibrate, has its own page.",
  "summary_technical": "Class page. MeSH descriptor D058607 (Fibric Acids) is a broad match: its scope note describes compounds that share, or vary, the fibric acid structure, a chemical group rather than the medicine class; Fibric Acid Derivatives is a MeSH entry term (read 2026-11-18, hash only). RxClass gives fenofibrate and gemfibrozil the chemical class Fibric Acids and the pharmacologic class Peroxisome Proliferator-activated Receptor alpha Agonist (from US drug labels, read 2026-11-18). The Antara label read (Lupin Pharmaceuticals, NDA021695, effective 2025-10-01 in openFDA) says fenofibric acid, the active moiety, acts by activating the PPAR alpha receptor. The MedlinePlus cholesterol medicines page adds that taking fibrates together with another class of cholesterol medicine might raise the risk of side effects. No brand-name gemfibrozil label was returned by openFDA, and one member substance, fenofibrate, is recorded; gemfibrozil has no page. No trial result and no dose is recorded.",
  "editorial_state": "draft",
  "last_substantive_edit": "2026-11-18",
  "last_evidence_check": "2026-11-18",
  "next_review_due": "2027-05-18",
  "identifiers": [
    {
      "scheme": "mesh",
      "value": "D058607",
      "normalized_value": "D058607",
      "match": "broad",
      "version": "id.nlm.nih.gov linked data, retrieved 2026-11-18",
      "label": null,
      "from_source": false
    }
  ],
  "navigation": {
    "cardio": {
      "system": [
        "metabolism"
      ],
      "condition-area": [
        "risk-and-prevention",
        "diabetes-and-metabolic-disease"
      ]
    }
  },
  "payload": {
    "level": "class",
    "mechanism": "The Antara label says fenofibric acid, by activating the PPAR alpha receptor, increases lipolysis and the elimination of triglyceride-rich particles from plasma."
  },
  "content_digest": "2cdecb34977a98c1f1085208e309357afc597159bc63d2837a18e00544045482",
  "review": {
    "content_digest": "2cdecb34977a98c1f1085208e309357afc597159bc63d2837a18e00544045482",
    "current": [],
    "conflicting": [],
    "stale": [],
    "inactive": []
  },
  "claims": [],
  "decisions": [],
  "milestones": [],
  "relationships": {
    "outgoing": [
      {
        "predicate": "part_of",
        "label": "Files under this front",
        "clinical_claim_not_fact": false,
        "family": "navigation",
        "other_entity_id": "cardio:front-medicines",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": null,
        "primary": true,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "related_to",
        "label": "MedlinePlus: fibrates lower triglycerides",
        "clinical_claim_not_fact": false,
        "family": "navigation",
        "other_entity_id": "cardio:hypertriglyceridemia",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": null,
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "related_to",
        "label": "MedlinePlus: taking fibrates with statins might raise the risk of side effects",
        "clinical_claim_not_fact": false,
        "family": "navigation",
        "other_entity_id": "cardio:statins",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": null,
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      }
    ],
    "incoming": [
      {
        "predicate": "subtype_of",
        "label": "Has subtype",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:fenofibrate",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:rxclass-8703-2026-11-18",
          "locator": "rxclassDrugInfoList.rxclassDrugInfo[1].rxclassMinConceptItem.className"
        },
        "primary": true,
        "role": null,
        "valid_from": null,
        "valid_to": null
      }
    ]
  },
  "page_path": "drugs/fibrates/",
  "context_path": "api/v1/context/cardio--fibrates.md"
}
